Sinopharm Tech Holdings Ltd
Sinopharm Tech Holdings Ltd exhibits a negative equity position of -36.87 million HKD, with a debt-to-equity ratio of -0.69, indicating a leveraged capital structure and a negative net worth. The company's liquidity position is weak, as evidenced by a current ratio of 0.72, suggesting that current liabilities exceed current assets. The operating cash flow of -5.70 million HKD and free cash flow of -0.04 million HKD further highlight the company's cash flow challenges. Profitability metrics show a mixed picture. The company reported a gross profit of 14.23 million HKD and operating income of 4.78 million HKD, but net income was negative at -0.87 million HKD. Return on equity is 2.35%, while return on assets is -1.68%, indicating poor asset utilization and equity returns. These figures fall below the typical performance of the Diversified Industrial Goods Wholesale industry, where positive net income and higher ROE are expected. The company operates through three segments: Supply Chain Services, Internet Plus Solutions Services, and Manufacturing and Distribution of Personal Protective Equipment. The Supply Chain Services segment is the primary revenue driver, but the company's financial snapshot does not provide segment-specific revenue breakdowns. The geographic exposure is not disclosed, but the company is headquartered in Hong Kong, suggesting potential regional concentration in the Asia-Pacific market. Growth trajectory appears constrained. The company reported a revenue of 61.25 million HKD in the latest period, but there is no historical revenue data provided to assess growth trends. The absence of capital expenditure and the negative net income suggest limited reinvestment and expansion activity. Analyst estimates for the most recent period show a revenue of 144.09 million HKD, but this may reflect a different reporting period or include non-operational revenue. Risk factors include liquidity constraints and a negative net worth. The company's liquidity risk is rated as medium, with a key flag indicating negative net cash after subtracting total debt. The dilution risk is low, but the negative equity position could lead to shareholder dilution if the company requires additional capital. The absence of capital expenditure and the negative operating cash flow suggest a lack of investment in growth or operational improvements. Recent events include the latest financial results showing a net loss of -0.87 million HKD and a negative EPS of -2.51 HKD. The company's financial performance has not met typical expectations for a business in the Diversified Industrial Goods Wholesale industry, and there are no disclosed recent filings or transcripts to provide further insight into strategic initiatives or operational changes.
Business. Sinopharm Tech Holdings Ltd operates as an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business, generating revenue through supply chain services, Internet Plus solutions, and personal protective equipment manufacturing and distribution.
Classification. Sinopharm Tech Holdings Ltd is classified under the industry Diversified Industrial Goods Wholesale within the Industrial & Commercial Services business sector, with a classification confidence of 0.92.
- Sinopharm Tech Holdings Ltd has a negative equity position and a weak liquidity position, with a current ratio of 0.72.
- The company reported a net loss of -0.87 million HKD, with a return on equity of 2.35% and a negative return on assets of -1.68%.
- The company operates through three segments, but segment-specific revenue data is not disclosed.
- Growth appears limited, with no capital expenditure and a negative operating cash flow.
- Liquidity risk is medium, and the company's financial position suggests potential dilution pressure if additional capital is required.
- --
- # RATIONALES
- ```json
- Net cash is negative after subtracting total debt.